Finan B, Mller TD, Clemmensen C, et al
Reduction of Abdominal and Visceral Fat : Animal and early human models have demonstrated a preferential reduction of abdominal fat following subcutaneous administration of AOD-9604
Recommendations : Use for 412 weeks , then take 4+ weeks off before restarting Monitor subjective feedback: sleep, digestion, energy, training response Reassess if using with other peptides or GH secretagogues to avoid overstimulation Who Should Be Cautious
Hypoxic epithelial necrosis triggers neutrophilic inflammation via IL-1 receptor signaling in cystic fibrosis lung disease
Use a sterile syringe to draw bacteriostatic water (BAC water), inject it slowly down the inside vial wall, and gently swirl until fully dissolved
Following a standardized process reduces the risk of contamination and ensures the tirzepatide remains potent